NIH Study Indicates J&J Vaccine Recipients Could Benefit From Pfizer, Moderna Boosters

The NIH released findings of a study that say recipients of the Johnson & Johnson COVID-19 vaccine may benefit from getting Pfizer or Moderna boosters as the antibody levels from those shots were seen as more robust than from a Johnson & Johnson booster.
More Videos
Best of CES 2026: Rise of the Robots!
From autonomous bots keeping airports running to humanoids that might become your best friend, take an exclusive look at the machines redefining how we live
Load More